Julia Hess

Head of competence field “Experimental Translational Oncology”

+49 89 3187 3517 julia.hess@helmholtz-munich.de

Gebäude / Raum: 57/031

Julia Hess is a biologist working in translational oncology and acting as a link between the research unit and clinical partners.

She leads the competence field “Experimental Translational Oncology” in the research unit Translational Metabolic Oncology (TMO) with a focus on generating clinical cohorts of cancer patients and omics data at multiple levels to identify prognostic stratification markers and develop targets for novel therapeutic approaches in precision oncology.

Julia Hess is currently completing her habilitation at the Medical Faculty of the LMU.

translational oncologymolecular mechanisms prognostic stratification markers therapeutic targets and intervention head and neck cancer clinical cohorts: biometerial, clinical data, multi-omics data cancer cell culture models

Hess J, Unger K, Maihoefer C, Schüttrumpf L, Weber P, Marschner S, Wintergerst L, Pflugradt L, Baumeister P, Walch A, Woischke C, Kirchner T, Werner M, Sörensen K, Baumann M, Tinhofer I, Combs SE, Debus J, Schäfer H, Krause M, Linge A, von der Grün J, Stuschke M, Zips D, Canis M, Lauber K, Ganswindt U, Henke M, Zitzelsberger H, Belka C

Integration of p16/HPV DNA status with a 24-miRNA-defined molecular phenotype improves clinically relevant stratification of head and neck cancer patients

Weber P, Kunstner A, Hess J, Unger K, Marschner S, Idel C, Ribbat-Idel J, Baumeister P, Gires O, Walz C, Rietzler S, Valeanu L, Herkommer T, Kreutzer L, Klymenko O, Drexler G, Kirchner T, Maihofer C, Ganswindt U, Walch A, Sterr M, Lickert H, Canis M, Rades D, Perner S, Berriel Diaz M, Herzig S, Lauber K, Wollenberg B, Busch H, Belka C, Zitzelsberger H

Hess J, Unger K, Maihoefer C, Schuttrumpf L, Wintergerst L, Heider T, Weber P, Marschner S, Braselmann H, Samaga D, Kuger S, Pflugradt U, Baumeister P, Walch A, Woischke C, Kirchner T, Werner M, Werner K, Baumann M, Budach V, Combs SE, Debus J, Grosu AL, Krause M, Linge A, Rodel C, Stuschke M, Zips D, Zitzelsberger H, Ganswindt U, Henke M, Belka C

A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection

Wintergerst, L.; Selmansberger, M.; Maihoefer, C.; Schuttrumpf, L.; Walch, A.; Wilke, C.; Pitea, A.; Woischke, C.; Baumeister, P.; Kirchner, T.; Belka, C.; Ganswindt, U.; Zitzelsberger, H.; Unger, K.; Hess, J

A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC)

Hess J, Unger K, Orth M, Schotz U, Schuttrumpf L, Zangen V, Gimenez-Aznar I, Michna A, Schneider L, Stamp R, Selmansberger M, Braselmann H, Hieber L, Drexler GA, Kuger S, Klein D, Jendrossek V, Friedl AA, Belka C, Zitzelsberger H, Lauber K

Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance

Dr. Julia Hess

Academic Career and Research Areas

Fields of Work and Expertise

Publications